Cambridge, UK | 1st November 2016.

 

Isogenica has recently signed with two separate biotech companies to use its proprietary CIS display platform in the discovery of novel scaffold binders as biotherapeutics. CIS display is an in vitro display technology which is very well suited to the rapid panning of large and diverse libraries